25 May 2020 - Vaccine manufacturer CSL has plans in place to manufacture a COVID-19 vaccine onshore as it confirms it will push any distributor to reserve a sufficient quantity of jabs for Australians.
CSL is working with the University of Queensland and the CSIRO to develop a protein-based vaccine.
As well as providing technical expertise, it has made its adjuvant — a substance added to a vaccine to boost the immune response — available to UQ to be added to the university’s vaccine candidate.